RFI-624-23-00001: Expand Family Planning and Sexual and Reproductive Health Activity (ExpandPF)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of West Africa USAID-Ghana notices from 2023.
West Africa USAID-Ghana offered grants of up to $45.0 million (at least $40.0 million) to any type of organization. It expected to make $45.0 million in total. Applications closed on February 28, 2023.
From the official notice on Grants.gov, last changed February 14, 2023. Checked November 7, 2026.
- Award ceiling$45.0 million
- Award floor$40.0 million
- Total funding$45.0 million
- Cost sharingRequired
- Funding typeCooperative Agreement
Key dates
| Posted | February 14, 2023 |
|---|---|
| Deadline | February 28, 2023 |
| Archived by Grants.gov | March 30, 2023 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
U.S. and non-U.S. nongovernmental organizations, non-profit, private voluntary organizations, for-profit organizations willing to forego profit, colleges and universities, and public international organizations are eligible to submit comments/respond to this request for information. Faith-based and community-based organizations that fit the criteria above are also eligible to submit comments.
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $45.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
The United States Agency for International Development (USAID), West Africa is seeking comments only on the attached draft Program Description for its anticipated USAID/West Africa Expand Family Planning and Sexual and Reproductive Health Activity (ExpandPF). ExpandPF aims to support replication and scale-up of key High Impact Practices in Family Planning (FP HIPs) (i.e., immediate postpartum familing planning, postabortion family planning, adolescent responsive contraceptive services, task sharing, community health workers, and knowledge, beliefs, attitudes, and self-efficacy) in urban and peri-urban centers, with targeted service delivery in Cameroon, Côte d'Ivoire, Mauritania, and Togo. This is a Request for Information (RFI) only, NOT a Request for Applications (RFA). Responses to this RFI shall not be portrayed as applications and will not be accepted by the United States Government (USG) to form a binding agreement. This RFI must not be construed as a commitment by the USG to issue an award, or to pay for costs incurred in the preparation and submission of any comments. Responses/comments on this RFI are strictly voluntary. USAID/West Africa will not provide answers to any questions or inquiries submitted in response this request and respondents will not be notified of the result of the review. It should be noted that responding to this RFI will not give any advantage to any organization in case of any subsequent award decision by USAID. USAID/West Africa may use the information provided to refine the Program Description. Therefore, please do not include proprietary information in your submission. In case a Notice of Funding Opportunity (NOFO) is issued, it will be synopsized on Grants.gov (www.grants.gov). It is the respondent’s responsibility to monitor the above website for the release of any further information.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFI-624-23-00001 still open?
No. It closed on February 28, 2023.
Who can apply for Expand Family Planning and Sexual and Reproductive Health Activity (ExpandPF)?
West Africa USAID-Ghana accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Expand Family Planning and Sexual and Reproductive Health Activity (ExpandPF)?
Closed February 28, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $45.0 million each. About $45.0 million in total.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)